RankingsPricing
  1. US-listed companies
  2. LIGAND PHARMACEUTICALS INC
  3. Financials
  4. Pretax margin (%)

LIGAND PHARMACEUTICALS INC【LGND】

Market cap
$3.9B
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 20241.5-96.89%
Dec 31, 202348.5+164.19%
Dec 31, 202218.4+7.52%
Dec 31, 202117.1-401.92%
Dec 31, 2020-5.7-100.85%
Dec 31, 2019662.3+860.82%
Dec 31, 201868.9+69.95%
Dec 31, 201740.6+455.27%
Dec 31, 20167.3-85.13%
Dec 31, 201549.1+180.53%
Dec 31, 201417.5-6.84%
Dec 31, 201318.8-252.66%
Dec 31, 2012-12.3+25.29%
Dec 31, 2011-9.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)